Plenty of pharma execs have decried Democrats’ new drug pricing law. But few are willing to say they might delay treatments for cancer patients if it means making more money.
You must log in or register to comment.
Oh please. Putting research/production focus on whatever drugs will make the biggest profit has always been the M.O.
